CFTR and cystic fibrosis: Although, many drugs including small molecule correctors (increase CFTR-expression) and potentiators (increase CFTR-function), have shown some potential in rescuing ΔF508-CFTR and decreasing CF pathogenesis, chronic inflammation and hypersecretion of mucus in CF airway remains a challenge by preventing the effective drug delivery to CF epithelia.